ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications

Journal of Crohn's and Colitis - Tập 13 Số 2 - Trang 144-164K - 2019

Christian Maaser¹, Andreas Sturm², Stephan R. Vavricka³, Torsten Kucharzik⁴, Gionata Fiorino⁵, Vito Annese⁶, Emma Calabrese⁷, Daniel C. Baumgart⁸, Dominik Bettenworth⁹, Paula Borralho^10,11, Johan Burisch^12,13, Fabiana Castiglione¹⁴, Rami Eliakim¹⁵, Pierre Ellul¹⁶, Yago González-Lama¹⁷, Hannah Gordon¹⁸, Steve Halligan¹⁹, Κωνσταντίνος Κατσάνος²⁰, Uri Kopylov¹⁵, Paulo Gustavo Kotze²¹, Eduards Krustiņš²², Andrea Laghi²³, Jimmy K. Limdi^24,25, Florian Rieder²⁶, Jordi Rimola²⁷, Stuart A. Taylor¹⁹, Damian Tolan²⁸, Patrick F. van Rheenen²⁹, Bram Verstockt³⁰, Jaap Stoker³¹

¹Outpatients Department of Gastroenterology, Hospital Lüneburg, Lüneburg, Germany

²Department of Gastroenterology, DRK Kliniken Berlin I Westend, Berlin, Germany

³Gastroenterology and Hepatology Center, Zurich, Switzerland

⁴Department of Internal Medicine and Gastroenterology, Hospital Lüneburg, Lüneburg, Germany

⁵Department of Gastroenterology, Humanitas Clinical and Research Institute, Milan, Italy

⁶Department of Gastroenterology, Valiant Clinic & American Hospital, Dubai, UAE

⁷Department of Systems Medicine, University of Rome “Tor Vergata”, Italy

⁸Division of Gastroenterology, University of Alberta, Edmonton, AB, Canada

⁹Department of Medicine B, Gastroenterology and Hepatology, University Hospital Münster, Münster, Germany

¹⁰Department of Anatomic Pathology, Hospital Cuf Descobertas

¹¹Department of Anatomic Pathology, Hospital Cuf Descobertas; Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal

¹²Department of Gastroenterology, North Zealand University Hospital

¹³Department of Gastroenterology, North Zealand University Hospital; Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Frederiksberg, Denmark

¹⁴Department of Clinical Medicine and Surgery, “Federico II” University of Naples, Naples, Italy

¹⁵Department of Gastroenterology, Sheba Medical Center, Sackler School of Medicine, Tel Aviv, Israel

¹⁶Department of Medicine, Mater Dei Hospital, Msida, Malta

¹⁷Department of Gastroenterology, University Hospital Puerta De Hierro, Majadahonda Madrid, Spain

¹⁸Department of Gastroenterology, Royal London Hospital, London, UK

¹⁹Centre for Medical Imaging, University College London, London, UK

²⁰Department of Gastroenterology and Hepatology, University and Medical School of Ioannina, Ioannina, Greece

²¹Colorectal Surgery Unit, Catholic University of Paraná (PUCPR), Curitiba, Brazil

²²Department of of Gastroenterology, Hepatology and Nutrition, Pauls Stradins Clinical University Hospital, Riga, Latvia

²³Department of Clinical and Surgical Translational Medicine, Sapienza University of Rome, Rome, Italy

²⁴Department of Gastroenterology, Pennine Acute Hospitals NHS Trust, Manchester; Manchester Academic Health Sciences Centre, University of Manchester, UK

²⁵Manchester Academic Health Sciences Centre, University of Manchester, UK

²⁶Department of Gastroenterology, Hepatology & Nutrition, Digestive Diseases and Surgery Institute, Cleveland Clinic, Cleveland, OH, USA

²⁷Department of Radiology, Hospital Clínic Barcelona, Barcelona, Spain

²⁸Clinical Radiology, St James’s University Hospital, Leeds, UK

²⁹Department of Paediatric Gastroenterology, Hepatology and Nutrition, University Medical Center Groningen, Groningen, The Netherlands

³⁰Department of Gastroenterology and Hepatology, University Hospitals Leuven and CHROMETA - Translational Research in Gastrointestinal Disorders, KU Leuven, Leuven, Belgium

³¹Department of Radiology and Nuclear Medicine, Academic Medical Center [AMC], University of Amsterdam, Amsterdam, The Netherlands

Tóm tắt

Từ khóa

Tài liệu tham khảo

Gomollón, 2017, Thirdd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016. Part 1: diagnosis and medical management, J Crohns Colitis, 11, 3, 10.1093/ecco-jcc/jjw168

Magro, 2017, Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders, J Crohns Colitis, 10.1093/ecco-jcc/jjx008

Vermeire, 2006, Laboratory markers in IBD: useful, magic, or unnecessary toys?, Gut, 55, 426, 10.1136/gut.2005.069476

Vermeire, 2005, The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases, Nat Clin Pract Gastroenterol Hepatol, 2, 580, 10.1038/ncpgasthep0359

Plevy, 2004, Do serological markers and cytokines determine the indeterminate?, J Clin Gastroenterol, 38, S51, 10.1097/01.mcg.0000124026.92823.fc

Poullis, 2002, Review article: faecal markers in the assessment of activity in inflammatory bowel disease, Aliment Pharmacol Ther, 16, 675, 10.1046/j.1365-2036.2002.01196.x

Langhorst, 2005, Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis, Inflamm Bowel Dis, 11, 1085, 10.1097/01.MIB.0000187980.08686.18

Konikoff, 2006, Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease, Inflamm Bowel Dis, 12, 524, 10.1097/00054725-200606000-00013

Costa, 2003, Role of faecal calprotectin as non-invasive marker of intestinal inflammation, Dig Liver Dis, 35, 642, 10.1016/S1590-8658(03)00381-5

Kane, 2003, Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation, Am J Gastroenterol, 98, 1309, 10.1111/j.1572-0241.2003.07458.x

Gisbert, 2009, Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse, Inflamm Bowel Dis, 15, 1190, 10.1002/ibd.20933

von Roon, 2007, Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy, Am J Gastroenterol, 102, 803, 10.1111/j.1572-0241.2007.01126.x

Schoepfer, 2009, Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes, Inflamm Bowel Dis, 15, 1851, 10.1002/ibd.20986

Schoepfer, 2008, Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies, Inflamm Bowel Dis, 14, 32, 10.1002/ibd.20275

Vinding, 2016, Fecal calprotectin measured by patients at home using smartphones–a new clinical tool in monitoring patients with inflammatory bowel disease, Inflamm Bowel Dis, 22, 336, 10.1097/MIB.0000000000000619

Lin, 2014, Meta-analysis: fecal calprotectin for assessment of inflammatory bowel disease activity, Inflamm Bowel Dis, 20, 1407, 10.1097/MIB.0000000000000057

Menees, 2015, A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS, Am J Gastroenterol, 110, 444, 10.1038/ajg.2015.6

Lozoya Angulo, 2017, Faecal calprotectin, a useful marker in discriminating between inflammatory bowel disease and functional gastrointestinal disorders, Gastroenterol Hepatol, 40, 125, 10.1016/j.gastrohep.2016.04.009

Fine, 1999, AGA technical review on the evaluation and management of chronic diarrhea, Gastroenterology, 116, 1464, 10.1016/S0016-5085(99)70513-5

Travis, 2003, Ulcerative colitis: clinical presentation and diagnosis., Inflammatory Bowel Diseases, 169

Bossuyt, 2006, Serologic markers in inflammatory bowel disease, Clin Chem, 52, 171, 10.1373/clinchem.2005.058560

Reese, 2006, Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease, Am J Gastroenterol, 101, 2410, 10.1111/j.1572-0241.2006.00840.x

Dubinsky, 2008, Increased immune reactivity predicts aggressive complicating Crohn’s disease in children, Clin Gastroenterol Hepatol, 6, 1105, 10.1016/j.cgh.2008.04.032

Ferrante, 2007, New serological markers in inflammatory bowel disease are associated with complicated disease behaviour, Gut, 56, 1394, 10.1136/gut.2006.108043

Mirkov, 2017, Genetics of inflammatory bowel disease: beyond NOD2, Lancet Gastroenterol Hepatol, 2, 224, 10.1016/S2468-1253(16)30111-X

Rahier, 2014, Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease, J Crohns Colitis, 8, 443, 10.1016/j.crohns.2013.12.013

Pizzi, 2006, Impact of chronic conditions on quality of life in patients with inflammatory bowel disease, Inflamm Bowel Dis, 12, 47, 10.1097/01.MIB.0000191670.04605.e7

Wells, 2006, Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients, Inflamm Bowel Dis, 12, 123, 10.1097/01.MIB.0000196646.64615.db

World Health Organization, 2011, Iron Deﬁciency Anemia Assessment, Prevention and Control. A Guide for Programme Managers

Testa, 2016, The burden of anaemia in patients with inflammatory bowel diseases, Dig Liver Dis, 48, 267, 10.1016/j.dld.2015.10.012

Dignass, 2015, European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases, J Crohns Colitis, 9, 211, 10.1093/ecco-jcc/jju009

Bergamaschi, 2010, Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatment, Haematologica, 95, 199, 10.3324/haematol.2009.009985

Goodhand, 2012, Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel disease, Inflamm Bowel Dis, 18, 513, 10.1002/ibd.21740

Weiss, 2005, Anemia of chronic disease, N Engl J Med, 352, 1011, 10.1056/NEJMra041809

Gasche, 2004, Iron, anaemia, and inflammatory bowel diseases, Gut, 53, 1190, 10.1136/gut.2003.035758

Martin, 2017, Current evaluation and management of anemia in patients with inflammatory bowel disease, Expert Rev Gastroenterol Hepatol, 11, 19, 10.1080/17474124.2017.1263566

Bentley, 2002, How could pathologists improve the initial diagnosis of colitis? Evidence from an international workshop, J Clin Pathol, 55, 955, 10.1136/jcp.55.12.955

Dejaco, 2003, Diagnosing colitis: a prospective study on essential parameters for reaching a diagnosis, Endoscopy, 35, 1004, 10.1055/s-2003-44593

Tanaka, 1999, Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn’s disease from ulcerative colitis, Scand J Gastroenterol, 34, 55, 10.1080/00365529950172844

Tanaka, 2000, Simple mucosal biopsy criteria differentiating among Crohn disease, ulcerative colitis, and other forms of colitis: measurement of validity, Scand J Gastroenterol, 35, 281, 10.1080/003655200750024155

Langner, 2014, The histopathological approach to inflammatory bowel disease: a practice guide, Virchows Arch, 464, 511

Tursi, 2008, Pattern of mucosal tumor necrosis factor-alpha expression in segmental colitis associated with diverticula suggests a truly autonomous clinical entity, Inflamm Bowel Dis, 14, 1315, 10.1002/ibd.20438

Lamps, 2007, Diverticular disease-associated segmental colitis, Clin Gastroenterol Hepatol, 5, 27, 10.1016/j.cgh.2006.10.024

Scowcroft, 1981, Colonoscopy in ischemic colitis, Gastrointest Endosc, 27, 156, 10.1016/S0016-5107(81)73182-1

Brandt, 2000, AGA technical review on intestinal ischemia. American Gastrointestinal Association, Gastroenterology, 118, 954, 10.1016/S0016-5085(00)70183-1

Bernstein, 1995, Patchiness of mucosal inflammation in treated ulcerative colitis: a prospective study, Gastrointest Endosc, 42, 232, 10.1016/S0016-5107(95)70097-8

Geboes, 2001, Pathology of inflammatory bowel diseases [IBD]: variability with time and treatment, Colorectal Dis, 3, 2, 10.1046/j.1463-1318.2001.00187.x

Markowitz, 1993, Atypical rectosigmoid histology in children with newly diagnosed ulcerative colitis, Am J Gastroenterol, 88, 2034

Robert, 2004, Patterns of inflammation in mucosal biopsies of ulcerative colitis: perceived differences in pediatric populations are limited to children younger than 10 years, Am J Surg Pathol, 28, 183, 10.1097/00000478-200402000-00005

Tanaka, 1990, The pathological diagnosis and differential diagnosis of Crohn’s disease, Hepatogastroenterology, 37, 18

Magro, 2013, European consensus on the histopathology of inflammatory bowel disease, J Crohns Colitis, 7, 827, 10.1016/j.crohns.2013.06.001

Navaneethan, 2012, Severe disease on endoscopy and steroid use increase the risk for bowel perforation during colonoscopy in inflammatory bowel disease patients, J Crohns Colitis, 6, 470, 10.1016/j.crohns.2011.10.005

Terheggen, 2008, Safety, feasibility, and tolerability of ileocolonoscopy in inflammatory bowel disease, Endoscopy, 40, 656, 10.1055/s-2008-1077445

Record, 1981, Flexible sigmoidoscopy in outpatients with suspected colonic disease, Br Med J, 283, 1291, 10.1136/bmj.283.6302.1291

Surawicz, 1994, Mucosal biopsy diagnosis of colitis: acute self-limited colitis and idiopathic inflammatory bowel disease, Gastroenterology, 107, 755, 10.1016/0016-5085(94)90124-4

Kopylov, 2017, Diagnostic yield of capsule endoscopy versus magnetic resonance enterography and small bowel contrast ultrasound in the evaluation of small bowel Crohn’s disease: Systematic review and meta-analysis, Dig Liver Dis, 10.1016/j.dld.2017.04.013

Rozendorn, 2016, Prediction of patency capsule retention in known Crohn’s disease patients by using magnetic resonance imaging, Gastrointest Endosc, 83, 182, 10.1016/j.gie.2015.05.048

Katsinelos, 2011, Diagnostic yield and clinical impact of wireless capsule endoscopy in patients with chronic abdominal pain with or without diarrhea: a Greek multicenter study, Eur J Intern Med, 22, e63, 10.1016/j.ejim.2011.06.012

De Bona, 2006, Capsule endoscopy findings in patients with suspected Crohn’s disease and biochemical markers of inflammation, Dig Liver Dis, 38, 331, 10.1016/j.dld.2006.02.004

Kopylov, 2015, Small bowel capsule endoscopy in the management of established Crohn’s disease: clinical impact, safety, and correlation with inflammatory biomarkers, Inflamm Bowel Dis, 21, 93, 10.1097/MIB.0000000000000255

Kopylov, 2015, Detection of small bowel mucosal healing and deep remission in patients with known small bowel Crohn’s disease using biomarkers, capsule endoscopy, and imaging, Am J Gastroenterol, 110, 1316, 10.1038/ajg.2015.221

Kopylov, 2016, Fecal calprotectin for the prediction of small bowel Crohn’s disease by capsule endoscopy: a systematic review and meta-analysis, Eur J Gastroenterol Hepatol, 28, 1137, 10.1097/MEG.0000000000000692

Gölder, 2006, Comparison of capsule endoscopy and magnetic resonance [MR] enteroclysis in suspected small bowel disease, Int J Colorectal Dis, 21, 97, 10.1007/s00384-005-0755-0

Triester, 2006, A meta-analysis of the yield of capsule endoscopy compared to other diagnostic modalities in patients with non-stricturing small bowel Crohn’s disease, Am J Gastroenterol, 101, 954, 10.1111/j.1572-0241.2006.00506.x

Van Weyenberg, 2013, Comparison of MR enteroclysis with video capsule endoscopy in the investigation of small-intestinal disease, Abdom Imaging, 38, 42, 10.1007/s00261-012-9892-4

Postgate, 2008, Safety, reliability and limitations of the given patency capsule in patients at risk of capsule retention: a 3-year technical review, Dig Dis Sci, 53, 2732, 10.1007/s10620-008-0210-5

Cheifetz, 2006, The risk of retention of the capsule endoscope in patients with known or suspected Crohn’s disease, Am J Gastroenterol, 101, 2218, 10.1111/j.1572-0241.2006.00761.x

Liao, 2010, Indications and detection, completion, and retention rates of small bowel capsule endoscopy: a systematic review, Gastrointest Endosc, 71, 280, 10.1016/j.gie.2009.09.031

Höög, 2012, Capsule retentions and incomplete capsule endoscopy examinations: an analysis of 2300 examinations, Gastroenterol Res Pract, 2012, 518718, 10.1155/2012/518718

Nemeth, 2016, Use of patency capsule in patients with established Crohn’s disease, Endoscopy, 48, 373

Lewis, 2008, Expanding role of capsule endoscopy in inflammatory bowel disease, World J Gastroenterol, 14, 4137, 10.3748/wjg.14.4137

Yadav, 2011, Performance of the patency capsule compared with nonenteroclysis radiologic examinations in patients with known or suspected intestinal strictures, Gastrointest Endosc, 74, 834, 10.1016/j.gie.2011.05.038

Jensen, 2017, Capsule endoscopy for the diagnosis and follow up of Crohn’s disease: a comprehensive review of current status, Ann Gastroenterol, 30, 168

Rutgeerts, 1980, Crohn’s disease of the stomach and duodenum: A clinical study with emphasis on the value of endoscopy and endoscopic biopsies, Endoscopy, 12, 288, 10.1055/s-2007-1021762

Wagtmans, 1997, Crohn’s disease of the upper gastrointestinal tract, Neth J Med, 50, S2, 10.1016/S0300-2977(96)00063-0

Witte, 1998, Crohn’s disease of the upper gastrointestinal tract: the value of endoscopic examination, Scand J Gastroenterol Suppl, 225, 100

Annunziata, 2012, Upper gastrointestinal involvement of Crohn’s disease: a prospective study on the role of upper endoscopy in the diagnostic work-up, Dig Dis Sci, 57, 1618, 10.1007/s10620-012-2072-0

Casella, 2010, Prevalence of celiac disease in inflammatory bowel diseases: an IG-IBD multicentre study, Dig Liver Dis, 42, 175, 10.1016/j.dld.2009.08.005

Samuel, 2012, Endoscopic skipping of the distal terminal ileum in Crohn’s disease can lead to negative results from ileocolonoscopy, Clin Gastroenterol Hepatol, 10, 1253, 10.1016/j.cgh.2012.03.026

Qiu, 2014, Systematic review with meta-analysis: magnetic resonance enterography vs. computed tomography enterography for evaluating disease activity in small bowel Crohn’s disease, Aliment Pharmacol Ther, 40, 134, 10.1111/apt.12815

Panés, 2011, Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease, Aliment Pharmacol Ther, 34, 125, 10.1111/j.1365-2036.2011.04710.x

Fiorino, 2011, Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn’s disease, Inflamm Bowel Dis, 17, 1073, 10.1002/ibd.21533

Puylaert, 2015, Grading of Crohn’s disease activity using CT, MRI, US and scintigraphy: a meta-analysis, Eur Radiol, 25, 3295, 10.1007/s00330-015-3737-9

Messaris, 2010, Role of magnetic resonance enterography in the management of Crohn disease, Arch Surg, 145, 471, 10.1001/archsurg.2010.68

Mendoza, 2012, Using of magnetic resonance enterography in the management of Crohn’s disease of the small intestine: first year of experience, Rev Esp Enferm Dig, 104, 578, 10.4321/S1130-01082012001100005

Castiglione, 2013, Noninvasive diagnosis of small bowel Crohn’s disease: direct comparison of bowel sonography and magnetic resonance enterography, Inflamm Bowel Dis, 19, 991, 10.1097/MIB.0b013e3182802b87

Taylor, 2018, Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn’s disease [METRIC]: a multicentre trial, Lancet Gastroenterol Hepatol, 3, 548, 10.1016/S2468-1253(18)30161-4

Calabrese, 2016, Bowel ultrasonography in the management of Crohn’s disease. A review with recommendations of an international panel of experts, Inflamm Bowel Dis, 22, 1168, 10.1097/MIB.0000000000000706

Choi, 2017, Effectiveness of capsule endoscopy compared with other diagnostic modalities in patients with small bowel Crohn’s disease: a meta-analysis, Gut Liver, 11, 62, 10.5009/gnl16015

Mow, 2004, Initial experience with wireless capsule enteroscopy in the diagnosis and management of inflammatory bowel disease, Clin Gastroenterol Hepatol, 2, 31, 10.1016/S1542-3565(03)00289-1

Mehdizadeh, 2008, Diagnostic yield of capsule endoscopy in ulcerative colitis and inflammatory bowel disease of unclassified type [IBDU], Endoscopy, 40, 30, 10.1055/s-2007-995359

Maunoury, 2007, Value of wireless capsule endoscopy in patients with indeterminate colitis [inflammatory bowel disease type unclassified], Inflamm Bowel Dis, 13, 152, 10.1002/ibd.20060

Cohen, 2008, Capsule endoscopy may reclassify pediatric inflammatory bowel disease: a historical analysis, J Pediatr Gastroenterol Nutr, 47, 31, 10.1097/MPG.0b013e318160df85

Higurashi, 2011, Capsule-endoscopic findings of ulcerative colitis patients, Digestion, 84, 306, 10.1159/000333086

Monteiro, 2017, Essential role of small bowel capsule endoscopy in reclassification of colonic inflammatory bowel disease type unclassified, World J Gastrointest Endosc, 9, 34, 10.4253/wjge.v9.i1.34

Keighley, 1986, Current status and influence of operation on perianal Crohn’s disease, Int J Colorectal Dis, 1, 104, 10.1007/BF01648416

Hellers, 1980, Occurrence and outcome after primary treatment of anal fistulae in Crohn’s disease, Gut, 21, 525, 10.1136/gut.21.6.525

Schwartz, 2002, The natural history of fistulizing Crohn’s disease in Olmsted County, Minnesota, Gastroenterology, 122, 875, 10.1053/gast.2002.32362

Tang, 2006, Are perineal and luminal fistulas associated in Crohn’s disease? A population-based study, Clin Gastroenterol Hepatol, 4, 1130, 10.1016/j.cgh.2006.06.021

Panes, 2013, Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines, J Crohns Colitis, 7, 556, 10.1016/j.crohns.2013.02.020

Sandborn, 2003, AGA technical review on perianal Crohn’s disease, Gastroenterology, 125, 1508, 10.1016/j.gastro.2003.08.025

Makowiec, 1997, Perianal abscess in Crohn’s disease, Dis Colon Rectum, 40, 443, 10.1007/BF02258390

Regueiro, 2002, The role of endoscopy in the evaluation of fistulizing Crohn’s disease, Gastrointest Endosc Clin N Am, 12, 621, 10.1016/S1052-5157(02)00013-2

Adler, 2012, Does capsule endoscopy have an added value in patients with perianal disease and a negative work up for Crohn’s disease?, World J Gastrointest Endosc, 4, 185, 10.4253/wjge.v4.i5.185

Gionchetti, 2017, European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016. Part 2: Surgical management and special situations, J Crohns Colitis, 11, 135, 10.1093/ecco-jcc/jjw169

Bell, 2003, The clinical course of fistulating Crohn’s disease, Aliment Pharmacol Ther, 17, 1145, 10.1046/j.1365-2036.2003.01561.x

Frøslie, 2007, Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort, Gastroenterology, 133, 412, 10.1053/j.gastro.2007.05.051

Shah, 2016, Mucosal healing is associated with improved long-term outcomes of patients with ulcerative colitis: a systematic review and meta-analysis, Clin Gastroenterol Hepatol, 14, 1245, 10.1016/j.cgh.2016.01.015

Peyrin-Biroulet, 2015, Selecting therapeutic targets in Inflammatory Bowel Disease [STRIDE]: determining therapeutic goals for treat-to-target, Am J Gastroenterol, 110, 1324, 10.1038/ajg.2015.233

Cholapranee, 2017, Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn’s disease and ulcerative colitis controlled trials, Aliment Pharmacol Ther, 45, 1291, 10.1111/apt.14030

Mosli, 2015, C-reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and meta-analysis, Am J Gastroenterol, 110, 802, 10.1038/ajg.2015.120

Zittan, 2016, Low fecal calprotectin correlates with histological remission and mucosal healing in ulcerative colitis and colonic Crohn’s disease, Inflamm Bowel Dis, 22, 623, 10.1097/MIB.0000000000000652

Lee, 2017, Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis, BMC Gastroenterol, 17, 110, 10.1186/s12876-017-0669-7

Patel, 2017, Fecal calprotectin levels predict histological healing in ulcerative colitis, Inflamm Bowel Dis, 23, 1600, 10.1097/MIB.0000000000001157

Parente, 2003, Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical location within the bowel, Aliment Pharmacol Ther, 18, 1009, 10.1046/j.1365-2036.2003.01796.x

Parente, 2010, Are colonoscopy and bowel ultrasound useful for assessing response to short-term therapy and predicting disease outcome of moderate-to-severe forms of ulcerative colitis?: a prospective study, Am J Gastroenterol, 105, 1150, 10.1038/ajg.2009.672

Bremner, 2006, Sonographic evaluation of inflammatory bowel disease: a prospective, blinded, comparative study, Pediatr Radiol, 36, 947, 10.1007/s00247-006-0245-8

Yamamoto, 2015, Consecutive monitoring of faecal calprotectin during mesalazine suppository therapy for active rectal inflammation in ulcerative colitis, Aliment Pharmacol Ther, 42, 549, 10.1111/apt.13308

Ellrichmann, 2014, Endoscopic ultrasound of the colon for the differentiation of Crohn’s disease and ulcerative colitis in comparison with healthy controls, Aliment Pharmacol Ther, 39, 823, 10.1111/apt.12671

Nozue, 2000, Assessment of disease activity and extent by magnetic resonance imaging in ulcerative colitis, Pediatr Int, 42, 285, 10.1046/j.1442-200x.2000.01218.x

Ajaj, 2005, Magnetic resonance colonography for the detection of inflammatory diseases of the large bowel: quantifying the inflammatory activity, Gut, 54, 257, 10.1136/gut.2003.037085

Langhorst, 2007, MR colonography without bowel purgation for the assessment of inflammatory bowel diseases: diagnostic accuracy and patient acceptance, Inflamm Bowel Dis, 13, 1001, 10.1002/ibd.20140

Oussalah, 2010, Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease, Gut, 59, 1056, 10.1136/gut.2009.197665

Baert, 2010, Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn’s disease, Gastroenterology, 138, 463, 10.1053/j.gastro.2009.09.056

Colombel, 2010, Infliximab, azathioprine, or combination therapy for Crohn’s disease, N Engl J Med, 362, 1383, 10.1056/NEJMoa0904492

Colombel, 2014, Adalimumab induces deep remission in patients with Crohn’s disease, Clin Gastroenterol Hepatol, 12, 414, 10.1016/j.cgh.2013.06.019

Colombel, 2015, Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn’s disease a SONIC post hoc analysis, Aliment Pharmacol Ther, 41, 734, 10.1111/apt.13139

Carvalho, 2014, Mucosal healing in Crohn’s disease are we reaching as far as possible with capsule endoscopy?, J Crohns Colitis, 8, 1566, 10.1016/j.crohns.2014.06.008

Peyrin-Biroulet, 2014, Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn’s disease in the SONIC trial, Gut, 63, 88, 10.1136/gutjnl-2013-304984

Kiss, 2011, Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn’s disease, Aliment Pharmacol Ther, 34, 911, 10.1111/j.1365-2036.2011.04827.x

Parente, 2004, Oral contrast enhanced bowel ultrasonography in the assessment of small intestine Crohn’s disease. A prospective comparison with conventional ultrasound, x ray studies, and ileocolonoscopy, Gut, 53, 1652, 10.1136/gut.2004.041038

Kucharzik, 2017, Use of intestinal ultrasound to monitor Crohn’s disease activity, Clin Gastroenterol Hepatol, 15, 535, 10.1016/j.cgh.2016.10.040

Saevik, 2014, Bowel perfusion measured with dynamic contrast-enhanced ultrasound predicts treatment outcome in patients with Crohn’s disease, Inflamm Bowel Dis, 20, 2029, 10.1097/MIB.0000000000000159

Castiglione, 2013, Transmural healing evaluated by bowel sonography in patients with Crohn’s disease on maintenance treatment with biologics, Inflamm Bowel Dis, 19, 1928

Civitelli, 2016, Looking beyond mucosal healing: effect of biologic therapy on transmural healing in pediatric Crohn’s disease, Inflamm Bowel Dis, 22, 2418, 10.1097/MIB.0000000000000897

Ripollés, 2016, Ultrasonographic changes at 12 weeks of anti-TNF drugs predict 1-year sonographic response and clinical outcome in Crohn’s disease: a multicenter study, Inflamm Bowel Dis, 22, 2465, 10.1097/MIB.0000000000000882

Bruining, 2011, Computed tomography enterography detects intestinal wall changes and effects of treatment in patients with Crohn’s disease, Clin Gastroenterol Hepatol, 9, 679, 10.1016/j.cgh.2011.04.025

Ordás, 2014, Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn’s disease, Gastroenterology, 146, 374, 10.1053/j.gastro.2013.10.055

Tielbeek, 2013, Serial magnetic resonance imaging for monitoring medical therapy effects in Crohn’s disease, Inflamm Bowel Dis, 19, 1943

Stoppino, 2016, Magnetic resonance enterography changes after antibody to tumor necrosis factor [anti-TNF] alpha therapy in Crohn’s disease: correlation with SES-CD and clinical-biological markers, BMC Med Imaging, 16, 37, 10.1186/s12880-016-0139-7

Paredes, 2010, Abdominal sonographic changes after antibody to tumor necrosis factor [anti-TNF] alpha therapy in Crohn’s Disease, Dig Dis Sci, 55, 404, 10.1007/s10620-009-0759-7

Moreno, 2014, Usefulness of abdominal ultrasonography in the analysis of endoscopic activity in patients with Crohn’s disease: changes following treatment with immunomodulators and/or anti-TNF antibodies, J Crohns Colitis, 8, 1079, 10.1016/j.crohns.2014.02.008

Ripollés, 2015, Ultrasonography and transmural healing in Crohn’s disease, Clin Gastroenterol Hepatol, 13, 1549, 10.1016/j.cgh.2015.02.026

Church, 2015, Systematic review with meta-analysis: magnetic resonance enterography signs for the detection of inflammation and intestinal damage in Crohn’s disease, Aliment Pharmacol Ther, 41, 153, 10.1111/apt.13024

Deepak, 2016, Radiological response is associated with better long-term outcomes and is a potential treatment target in patients with small bowel Crohn’s Disease, Am J Gastroenterol, 111, 997, 10.1038/ajg.2016.177

Jensen, 2011, Diagnostic accuracy of capsule endoscopy for small bowel Crohn’s disease is superior to that of MR enterography or CT enterography, Clin Gastroenterol Hepatol, 9, 124, 10.1016/j.cgh.2010.10.019

Efthymiou, 2008, Does clinical response correlate with mucosal healing in patients with Crohn’s disease of the small bowel? A prospective, case-series study using wireless capsule endoscopy, Inflamm Bowel Dis, 14, 1542, 10.1002/ibd.20509

Hall, 2014, A prospective 52-week mucosal healing assessment of small bowel Crohn’s disease as detected by capsule endoscopy, J Crohns Colitis, 8, 1601, 10.1016/j.crohns.2014.09.005

Niv, 2012, Validation of the Capsule Endoscopy Crohn’s Disease Activity Index [CECDAI or Niv score]: a multicenter prospective study, Endoscopy, 44, 21, 10.1055/s-0031-1291385

Gralnek, 2008, Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change, Aliment Pharmacol Ther, 27, 146, 10.1111/j.1365-2036.2007.03556.x

Turner, 2007, Esophageal, gastric, and duodenal manifestations of IBD and the role of upper endoscopy in IBD diagnosis, Curr Gastroenterol Rep, 9, 475, 10.1007/s11894-007-0062-8

Diaz, 2015, Upper gastrointestinal involvement in Crohn disease: histopathologic and endoscopic findings, South Med J, 108, 695, 10.14423/SMJ.0000000000000373

Attwood, 2008, Eosinophilic oesophagitis and other non-reflux inflammatory conditions of the oesophagus: diagnostic imaging and management, Best Pract Res Clin Gastroenterol, 22, 639, 10.1016/j.bpg.2007.12.003

Horsthuis, 2009, Magnetic resonance imaging for evaluation of disease activity in Crohn’s disease: a systematic review, Eur Radiol, 19, 1450, 10.1007/s00330-008-1287-0

Desmond, 2008, Crohn’s disease: factors associated with exposure to high levels of diagnostic radiation, Gut, 57, 1524, 10.1136/gut.2008.151415

Sandborn, 2002, A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn’s disease, Gastroenterology, 122, 512, 10.1053/gast.2002.31072

Irvine, 1995, Usual therapy improves perianal Crohn’s disease as measured by a new disease activity index. McMaster IBD Study Group, J Clin Gastroenterol, 20, 27, 10.1097/00004836-199501000-00008

Schoepfer, 2010, Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn’s disease population: results of the FACTS survey, Inflamm Bowel Dis, 16, 933, 10.1002/ibd.21127

Sands, 2004, Infliximab maintenance therapy for fistulizing Crohn’s disease, N Engl J Med, 350, 876, 10.1056/NEJMoa030815

Sandborn, 2003, Tacrolimus for the treatment of fistulas in patients with Crohn’s disease: a randomized, placebo-controlled trial, Gastroenterology, 125, 380, 10.1016/S0016-5085(03)00877-1

Pikarsky, 2002, Perianal Crohn disease: a new scoring system to evaluate and predict outcome of surgical intervention, Arch Surg, 137, 774, 10.1001/archsurg.137.7.774

Van Assche, 2003, Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn’s disease, Am J Gastroenterol, 98, 332, 10.1016/S0002-9270(02)05909-9

Karmiris, 2011, Long-term monitoring of infliximab therapy for perianal fistulizing Crohn’s disease by using magnetic resonance imaging, Clin Gastroenterol Hepatol, 9, 130, 10.1016/j.cgh.2010.10.022

Savoye-Collet, 2011, Fistulizing perianal Crohn’s disease: contrast-enhanced magnetic resonance imaging assessment at 1 year on maintenance anti-TNF-alpha therapy, Inflamm Bowel Dis, 17, 1751, 10.1002/ibd.21568

Horsthuis, 2009, Perianal Crohn disease: evaluation of dynamic contrast-enhanced MR imaging as an indicator of disease activity, Radiology, 251, 380, 10.1148/radiol.2512072128

Ng, 2009, Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn’s perineal fistulas, Am J Gastroenterol, 104, 2973, 10.1038/ajg.2009.509

Spradlin, 2008, A randomized prospective trial of endoscopic ultrasound to guide combination medical and surgical treatment for Crohn’s perianal fistulas, Am J Gastroenterol, 103, 2527, 10.1111/j.1572-0241.2008.02063.x

Guidi, 2008, Combined therapy with infliximab and seton drainage for perianal fistulizing Crohn’s disease with anal endosonographic monitoring: a single-centre experience, Tech Coloproctol, 12, 111, 10.1007/s10151-008-0411-0

Schwartz, 2001, A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn’s perianal fistulas, Gastroenterology, 121, 1064, 10.1053/gast.2001.28676

Buchanan, 2004, Clinical examination, endosonography, and MR imaging in preoperative assessment of fistula in ano: comparison with outcome-based reference standard, Radiology, 233, 674, 10.1148/radiol.2333031724

Siddiqui, 2012, A diagnostic accuracy meta-analysis of endoanal ultrasound and MRI for perianal fistula assessment, Dis Colon Rectum, 55, 576, 10.1097/DCR.0b013e318249d26c

Gecse, 2014, A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn’s disease, Gut, 63, 1381, 10.1136/gutjnl-2013-306709

Maconi, 2007, Transperineal ultrasound in the detection of perianal and rectovaginal fistulae in Crohn’s disease, Am J Gastroenterol, 102, 2214, 10.1111/j.1572-0241.2007.01441.x

Ben-Horin, 2011, Review article: loss of response to anti-TNF treatments in Crohn’s disease, Aliment Pharmacol Ther, 33, 987, 10.1111/j.1365-2036.2011.04612.x

Yanai, 2015, Levels of drug and antidrug antibodies are associated with outcome of interventions after loss of response to infliximab or adalimumab, Clin Gastroenterol Hepatol, 13, 522, 10.1016/j.cgh.2014.07.029

Ordás, 2012, Anti-TNF monoclonal antibodies in inflammatory bowel disease: pharmacokinetics-based dosing paradigms, Clin Pharmacol Ther, 91, 635, 10.1038/clpt.2011.328

Vande Casteele, 2015, The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn’s disease, Gut, 64, 1539, 10.1136/gutjnl-2014-307883

Radstake, 2009, Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis, Ann Rheum Dis, 68, 1739, 10.1136/ard.2008.092833

Moore, 2016, Systematic review and meta-analysis: serum infliximab levels during maintenance therapy and outcomes in inflammatory bowel disease, J Crohns Colitis, 10, 619, 10.1093/ecco-jcc/jjw007

Harzallah, 2017, Golimumab pharmacokinetics in ulcerative colitis: a literature review, Therap Adv Gastroenterol, 10, 89, 10.1177/1756283X16676194

Karmiris, 2009, Influence of trough serum levels and immunogenicity on long-term outcome of adalimumab therapy in Crohn’s disease, Gastroenterology, 137, 1628, 10.1053/j.gastro.2009.07.062

Vande Casteele, 2015, Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease, Gastroenterology, 148, 1320, 10.1053/j.gastro.2015.02.031

Zittan, 2016, Higher adalimumab drug levels are associated with mucosal healing in patients with Crohn’s disease, J Crohns Colitis, 10, 510, 10.1093/ecco-jcc/jjw014

Brandse, 2015, Loss of infliximab into feces is associated with lack of response to therapy in patients with severe ulcerative colitis, Gastroenterology, 149, 350, 10.1053/j.gastro.2015.04.016

Haines, 2011, Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease, Inflamm Bowel Dis, 17, 1301, 10.1002/ibd.21458

Heida, 2017, Clinical utility of fecal calprotectin monitoring in asymptomatic patients with inflammatory bowel disease: a systematic review and practical guide, Inflamm Bowel Dis, 23, 894, 10.1097/MIB.0000000000001082

Yamamoto, 2016, Serial monitoring of faecal calprotectin for the assessment of endoscopic recurrence in asymptomatic patients after ileocolonic resection for Crohn’s disease: a long-term prospective study, Therap Adv Gastroenterol, 9, 664, 10.1177/1756283X16646562

Zhulina, 2016, The prognostic significance of faecal calprotectin in patients with inactive inflammatory bowel disease, Aliment Pharmacol Ther, 44, 495, 10.1111/apt.13731

Langhorst, 2016, Faecal lactoferrin, calprotectin, PMN-elastase, CRP, and white blood cell count as indicators for mucosal healing and clinical course of disease in patients with mild to moderate ulcerative colitis: post hoc analysis of a prospective clinical trial, J Crohns Colitis, 10, 786, 10.1093/ecco-jcc/jjw044

Ferreiro-Iglesias, 2016, Fecal calprotectin as predictor of relapse in patients with inflammatory bowel disease under maintenance infliximab therapy, J Clin Gastroenterol, 50, 147, 10.1097/MCG.0000000000000312

De Vos, 2012, Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis, J Crohns Colitis, 6, 557, 10.1016/j.crohns.2011.11.002

Mao, 2012, Fecal calprotectin in predicting relapse of inflammatory bowel diseases: a meta-analysis of prospective studies, Inflamm Bowel Dis, 18, 1894, 10.1002/ibd.22861

Theede, 2016, Fecal calprotectin predicts relapse and histological mucosal healing in ulcerative colitis, Inflamm Bowel Dis, 22, 1042, 10.1097/MIB.0000000000000736

Lasson, 2015, Pharmacological intervention based on fecal calprotectin levels in patients with ulcerative colitis at high risk of a relapse: a prospective, randomized, controlled study, United European Gastroenterol J, 3, 72, 10.1177/2050640614560785

De Vos, 2013, Consecutive fecal calprotectin measurements to predict relapse in patients with ulcerative colitis receiving infliximab maintenance therapy, Inflamm Bowel Dis, 19, 2111, 10.1097/MIB.0b013e31829b2a37

Diederen, 2017, Raised faecal calprotectin is associated with subsequent symptomatic relapse, in children and adolescents with inflammatory bowel disease in clinical remission, Aliment Pharmacol Ther, 45, 951, 10.1111/apt.13950

Du, Within-stool and within-day sample variability of fecal calprotectin in patients with inflammatory bowel disease: a prospective observational study, J Clin Gastroenterol

Colombel, 2018, Effect of tight control management on Crohn’s disease [CALM]: a multicentre, randomised, controlled phase 3 trial, Lancet, 390, 2779, 10.1016/S0140-6736(17)32641-7

Glasziou, 2005, Monitoring in chronic disease: a rational approach, BMJ, 330, 644, 10.1136/bmj.330.7492.644

van Rheenen, 2014, Do not read single calprotectin measurements in isolation when monitoring your patients with inflammatory bowel disease, Inflamm Bowel Dis, 20, 1416, 10.1097/MIB.0000000000000107

Zubin, 2015, Predicting endoscopic Crohn’s disease activity before and after induction therapy in children: a comprehensive assessment of PCDAI, CRP, and fecal calprotectin, Inflamm Bowel Dis, 21, 1386

Wright, 2016, Comparison of fecal inflammatory markers in Crohn’s disease, Inflamm Bowel Dis, 22, 1086, 10.1097/MIB.0000000000000671

Höög, 2014, Capsule endoscopic findings correlate with fecal calprotectin and C-reactive protein in patients with suspected small bowel Crohn’s disease, Scand J Gastroenterol, 49, 1084, 10.3109/00365521.2014.920915

Bar-Gil Shitrit, 2017, A prospective study of fecal calprotectin and lactoferrin as predictors of small bowel Crohn’s disease in patients undergoing capsule endoscopy, Scand J Gastroenterol, 52, 328, 10.1080/00365521.2016.1253769

Greener, 2016, The impact of magnetic resonance enterography and capsule endoscopy on the re-classification of disease in patients with known Crohn’s disease: a prospective Israeli IBD Research Nucleus [IIRN] Study, J Crohns Colitis, 10, 525, 10.1093/ecco-jcc/jjw006

Yoon, 2017, Diagnostic performance of magnetic resonance enterography for detection of active inflammation in children and adolescents with inflammatory bowel disease: a systematic review and diagnostic meta-analysis, JAMA Pediatr, 171, 1208, 10.1001/jamapediatrics.2017.3400

Mocci, 2017, SICUS and CEUS imaging in Crohn’s disease: an update, J Ultrasound, 20, 1, 10.1007/s40477-016-0230-5

Kucharzik, 2017, The use of ultrasound in inflammatory bowel disease, Ann Gastroenterol, 30, 135

Barber, 2017, There is good agreement between MR enterography and bowel ultrasound with regards to disease location and activity in paediatric inflammatory bowel disease, Clin Radiol, 72, 590, 10.1016/j.crad.2017.02.008

Torres, 2015, Systematic review of effects of withdrawal of immunomodulators or biologic agents from patients with inflammatory bowel disease, Gastroenterology, 149, 1716, 10.1053/j.gastro.2015.08.055

Gisbert, 2016, The risk of relapse after anti-TNF discontinuation in inflammatory bowel disease: systematic review and meta-analysis, Am J Gastroenterol, 111, 632, 10.1038/ajg.2016.54

Kennedy, 2016, Relapse after withdrawal from anti-TNF therapy for inflammatory bowel disease: an observational study, plus systematic review and meta-analysis, Aliment Pharmacol Ther, 43, 910, 10.1111/apt.13547

Lémann, 2005, A randomized, double-blind, controlled withdrawal trial in Crohn’s disease patients in long-term remission on azathioprine, Gastroenterology, 128, 1812, 10.1053/j.gastro.2005.03.031

Louis, 2012, Maintenance of remission among patients with Crohn’s disease on antimetabolite therapy after infliximab therapy is stopped, Gastroenterology, 142, 63, 10.1053/j.gastro.2011.09.034

Ihekweazu, 2015, Diagnostic yield of routine enteropathogenic stool tests in pediatric ulcerative colitis, Ann Clin Lab Sci, 45, 639

Roy, 2016, Clostridium difficile infection: a rarity in patients receiving chronic antibiotic treatment for Crohn’s disease, Inflamm Bowel Dis, 22, 648, 10.1097/MIB.0000000000000641

Navaneethan, 2012, Clostridium difficile infection is associated with worse long term outcome in patients with ulcerative colitis, J Crohns Colitis, 6, 330, 10.1016/j.crohns.2011.09.005

Negrón, 2014, Clostridium difficile infection worsens the prognosis of ulcerative colitis, Can J Gastroenterol Hepatol, 28, 373, 10.1155/2014/914303

Negrón, 2016, Ulcerative colitis patients with clostridium difficile are at increased risk of death, colectomy, and postoperative complications: a population-based inception cohort study, Am J Gastroenterol, 111, 691, 10.1038/ajg.2016.106

Knösel, 2009, Prevalence of infectious pathogens in Crohn’s disease, Pathol Res Pract, 205, 223, 10.1016/j.prp.2008.04.018

Banerjee, 2009, High frequency of parasitic and viral stool pathogens in patients with active ulcerative colitis: report from a tropical country, Scand J Gastroenterol, 44, 325, 10.1080/00365520802556809

Zhang, 2016, Effects of cytomegalovirus infection on the prognosis of inflammatory bowel disease patients, Exp Ther Med, 12, 3287, 10.3892/etm.2016.3763

Shukla, Corticosteroids and thiopurines, but not tumor necrosis factor antagonists, are associated with cytomegalovirus reactivation in inflammatory bowel disease: a systematic review and meta-analysis, J Clin Gastroenterol

Kandiel, 2006, Cytomegalovirus colitis complicating inflammatory bowel disease, Am J Gastroenterol, 101, 2857, 10.1111/j.1572-0241.2006.00869.x

Kopylov, 2017, Impact of infliximab and cyclosporine on the risk of colectomy in hospitalized patients with ulcerative colitis complicated by Cytomegalovirus A multicenter retrospective study, Inflamm Bowel Dis, 23, 1605, 10.1097/MIB.0000000000001160

Jensen, 2011, Fecal calprotectin is equally sensitive in Crohn’s disease affecting the small bowel and colon, Scand J Gastroenterol, 46, 694, 10.3109/00365521.2011.560680

Arai, 2017, Level of fecal calprotectin correlates with seve small bowel Crohn’s disease, measured by balloon-assisted enteroscopy and computed tomography enterography, Clin Gastroenterol Hepatol, 15, 56, 10.1016/j.cgh.2016.08.015

Egea Valenzuela, 2016, Fecal calprotectin and C-reactive protein are associated with positive findings in capsule endoscopy in suspected small bowel Crohn’s disease, Rev Esp Enferm Dig, 108, 394, 10.17235/reed.2016.4318/2016

Costa, 2005, Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn’s disease, Gut, 54, 364, 10.1136/gut.2004.043406

Moniuszko, 2017, Rapid fecal calprotectin test for prediction of mucosal inflammation in ulcerative colitis and Crohn disease: a prospective cohort study, Pol Arch Intern Med, 127, 312

Schoepfer, 2010, Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn’s disease [SES-CD] than CRP, blood leukocytes, and the CDAI, Am J Gastroenterol, 105, 162, 10.1038/ajg.2009.545

Narin, 2004, Combined small and large bowel MR imaging in patients with Crohn’s disease: a feasibility study, Eur Radiol, 14, 1535, 10.1007/s00330-004-2364-7

Grand, 2012, MR enterography correlates highly with colonoscopy and histology for both distal ileal and colonic Crohn’s disease in 310 patients, Eur J Radiol, 81, e763, 10.1016/j.ejrad.2012.02.011

Narin, 2009, Comparison of MR enteroclysis with colonoscopy in Crohn’s disease–first locust bean gum study from Turkey, Saudi J Gastroenterol, 15, 253, 10.4103/1319-3767.56104

Rimola, 2010, Colonic Crohn’s disease: value of magnetic resonance colonography for detection and quantification of disease activity, Abdom Imaging, 35, 422, 10.1007/s00261-009-9545-4

Röttgen, 2006, Bowel wall enhancement in magnetic resonance colonography for assessing activity in Crohn’s disease, Clin Imaging, 30, 27, 10.1016/j.clinimag.2005.07.031

Hyun, 2011, Magnetic resonance enterocolonography is useful for simultaneous evaluation of small and large intestinal lesions in Crohn’s disease, Inflamm Bowel Dis, 17, 1063, 10.1002/ibd.21510

D’Haens, 2015, Safety and feasibility of using the second-generation pillcam colon capsule to assess active colonic Crohn’s disease, Clin Gastroenterol Hepatol, 13, 1480, 10.1016/j.cgh.2015.01.031

Negreanu, 2014, Role of capsule endoscopy Pillcam COLON 2 in patients with known or suspected Crohn’s disease who refused colonoscopy or underwent incomplete colonoscopic exam: a case series, Tech Coloproctol, 18, 277, 10.1007/s10151-013-1054-3

Shen, 2017, Is it a prime time for small bowel colon video capsule endoscopy to cover both sides of the ileocecal valve in Crohn’s disease?, Gastrointest Endosc, 85, 206, 10.1016/j.gie.2016.09.005

Griffin, 2012, Small bowel MR enterography: problem solving in Crohn’s disease, Insights Imaging, 3, 251, 10.1007/s13244-012-0154-3

Bickelhaupt, 2013, Crohn’s disease: small bowel motility impairment correlates with inflammatory-related markers C-reactive protein and calprotectin, Neurogastroenterol Motil, 25, 467, 10.1111/nmo.12088

Fornasa, 2011, Role of magnetic resonance enterography in differentiating between fibrotic and active inflammatory small bowel stenosis in patients with Crohn’s disease, J Clin Imaging Sci, 1, 35, 10.4103/2156-7514.82339

Giusti, 2010, Dynamic MRI of the small bowel: usefulness of quantitative contrast-enhancement parameters and time-signal intensity curves for differentiating between active and inactive Crohn’s disease, Abdom Imaging, 35, 646, 10.1007/s00261-010-9624-6

Hahnemann, 2015, Quantitative assessment of small bowel motility in patients with Crohn’s disease using dynamic MRI, Neurogastroenterol Motil, 27, 841, 10.1111/nmo.12558

Iwańczak, 2016, Assessment of magnetic resonance enterography in the diagnosis of small bowel diseases in children with Crohn’s disease, Adv Clin Exp Med, 25, 111, 10.17219/acem/32067

Li, 2017, Diffusion-weighted MRI enables to accurately grade inflammatory activity in patients of ileocolonic Crohn’s disease: results from an observational study, Inflamm Bowel Dis, 10.1097/MIB.0000000000001001

Li, 2016, CAIPIRINHA-accelerated T1w 3D-FLASH for small bowel MR imaging in pediatric patients with Crohn’s disease: assessment of image quality and diagnostic performance, World J Pediatr, 12, 455, 10.1007/s12519-016-0047-5

Ahmed, 2016, Magnetic resonance imaging of the small bowel in Crohn’s disease: a systematic review and meta-analysis, Can J Gastroenterol Hepatol, 2016, 7857352, 10.1155/2016/7857352

Cheriyan, 2013, Impact of magnetic resonance enterography in the management of small bowel Crohn’s disease, Eur J Gastroenterol Hepatol, 25, 550, 10.1097/MEG.0b013e32835d4e9c

Lang, 2015, Impact of small bowel MRI in routine clinical practice on staging of Crohn’s disease, J Crohns Colitis, 9, 784, 10.1093/ecco-jcc/jjv106

Gourtsoyiannis, 2006, Imaging of small intestinal Crohn’s disease: comparison between MR enteroclysis and conventional enteroclysis, Eur Radiol, 16, 1915, 10.1007/s00330-006-0248-8

Negaard, 2007, A prospective randomized comparison between two MRI studies of the small bowel in Crohn’s disease, the oral contrast method and MR enteroclysis, Eur Radiol, 17, 2294, 10.1007/s00330-007-0648-4

Negaard, 2008, MRI of the small bowel with oral contrast or nasojejunal intubation in Crohn’s disease: randomized comparison of patient acceptance, Scand J Gastroenterol, 43, 44, 10.1080/00365520701494813

Pallotta, 2013, Small intestine contrast ultrasonography in pediatric Crohn’s disease, J Pediatr, 163, 778, 10.1016/j.jpeds.2013.03.056

Pallotta, 2012, Small intestine contrast ultrasonography [SICUS] for the detection of small bowel complications in Crohn’s disease: a prospective comparative study versus intraoperative findings, Inflamm Bowel Dis, 18, 74, 10.1002/ibd.21678

Bhatnagar, 2017, Utility of MR enterography and ultrasound for the investigation of small bowel Crohn’s disease, J Magn Reson Imaging, 45, 1573, 10.1002/jmri.25569

Kumar, 2015, Small intestinal contrast ultrasonography for the detection of small bowel complications in Crohn’s disease: correlation with intraoperative findings and magnetic resonance enterography, J Gastroenterol Hepatol, 30, 86, 10.1111/jgh.12724

Onali, 2012, Small intestine contrast ultrasonography versus computed tomography enteroclysis for assessing ileal Crohn’s disease, World J Gastroenterol, 18, 6088, 10.3748/wjg.v18.i42.6088

Aloi, 2015, Magnetic resonance enterography, small-intestine contrast US, and capsule endoscopy to evaluate the small bowel in pediatric Crohn’s disease: a prospective, blinded, comparison study, Gastrointest Endosc, 81, 420, 10.1016/j.gie.2014.07.009

Calabrese, 2013, Accuracy of small-intestine contrast ultrasonography, compared with computed tomography enteroclysis, in characterizing lesions in patients with Crohn’s disease, Clin Gastroenterol Hepatol, 11, 950, 10.1016/j.cgh.2013.01.015

Quaia, 2013, Contrast-enhanced ultrasound of the small bowel in Crohn’s disease, Abdom Imaging, 38, 1005, 10.1007/s00261-013-0014-8

Dionisio, 2010, Capsule endoscopy has a significantly higher diagnostic yield in patients with suspected and established small bowel Crohn’s disease: a meta-analysis, Am J Gastroenterol, 105, 1240, 10.1038/ajg.2009.713

Efthymiou, 2009, Wireless capsule endoscopy versus enteroclysis in the diagnosis of small bowel Crohn’s disease, Eur J Gastroenterol Hepatol, 21, 866, 10.1097/MEG.0b013e32831af1ec

Flamant, 2013, The prevalence and outcome of jejunal lesions visualized by small bowel capsule endoscopy in Crohn’s disease, Inflamm Bowel Dis, 19, 1390, 10.1097/MIB.0b013e31828133c1

Gralnek, 2009, Evidence for capsule endoscopy in suspected small bowel Crohn’s disease: an evaluation of intergrading system concordance, J Insur Med, 41, 270

O’Donnell, 2009, The role of capsule endoscopy in small bowel Crohn’s disease, J Crohns Colitis, 3, 282, 10.1016/j.crohns.2009.07.002

Cotter, 2014, Tailoring Crohn’s disease treatment: the impact of small bowel capsule endoscopy, J Crohns Colitis, 8, 1610, 10.1016/j.crohns.2014.02.018

Cheon, 2007, Can we predict spontaneous capsule passage after retention? A nationwide study to evaluate the incidence and clinical outcomes of capsule retention, Endoscopy, 39, 1046, 10.1055/s-2007-966978

Albuquerque, 2016, Predictive factors of small bowel patency in Crohn’s disease patients, Rev Esp Enferm Dig, 108, 65

Dozsa, 2015, Cost-effectiveness analysis of capsule endoscopy using for diagnosing small bowel Crohn’s disease, Value Health, 18, A355, 10.1016/j.jval.2015.09.665

Dussault, 2013, Small bowel capsule endoscopy for management of Crohn’s disease: a retrospective tertiary care centre experience, Dig Liver Dis, 45, 558, 10.1016/j.dld.2012.11.004

Bernstein, 2005, A prospective comparison study of MRI versus small bowel follow-through in recurrent Crohn’s disease, Am J Gastroenterol, 100, 2493, 10.1111/j.1572-0241.2005.00239.x

Hafeez, 2011, Use of small bowel imaging for the diagnosis and staging of Crohn’s disease–a survey of current UK practice, Br J Radiol, 84, 508, 10.1259/bjr/65972479

Jaffe, 2007, Radiation doses from small bowel follow-through and abdominopelvic MDCT in Crohn’s disease, AJR Am J Roentgenol, 189, 1015, 10.2214/AJR.07.2427

Lai, 2013, Comparison of magnetic resonance enterography, capsule endoscopy and gastrointestinal radiography of children with small bowel Crohn’s disease, Exp Ther Med, 6, 115, 10.3892/etm.2013.1113

Jensen, 2011, Interobserver and intermodality agreement for detection of small bowel Crohn’s disease with MR enterography and CT enterography, Inflamm Bowel Dis, 17, 1081, 10.1002/ibd.21534

Makó, 2000, Enteroclysis and spiral CT examination in diagnosis and evaluation of small bowel Crohn’s disease, Eur J Radiol, 35, 168, 10.1016/S0720-048X(00)00239-4

Siddiki, 2009, Prospective comparison of state-of-the-art MR enterography and CT enterography in small bowel Crohn’s disease, AJR Am J Roentgenol, 193, 113, 10.2214/AJR.08.2027

Guidi, 2004, Clinical correlations of small bowel CT and contrast radiology findings in Crohn’s disease, Eur Rev Med Pharmacol Sci, 8, 215

Greenup, 2016, Medical imaging in small bowel Crohn’s disease-computer tomography enterography, magnetic resonance enterography, and ultrasound: “Which one is the best for what?”, Inflamm Bowel Dis, 22, 1246, 10.1097/MIB.0000000000000727

Ahmadi, 2010, Diagnostic value of noninvasive combined fluorine-18 labeled fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography enterography in active Crohn’s disease, Inflamm Bowel Dis, 16, 974, 10.1002/ibd.21153

Pellino, 2016, PET/MR versus PET/CT imaging: impact on the clinical management of small bowel Crohn’s disease, J Crohns Colitis, 10, 277, 10.1093/ecco-jcc/jjv207

Almer, 2007, Leukocyte scintigraphy compared to intraoperative small bowel enteroscopy and laparotomy findings in Crohn’s disease, Inflamm Bowel Dis, 13, 164, 10.1002/ibd.20001

Schoepfer, 2013, Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes, Inflamm Bowel Dis, 19, 332, 10.1097/MIB.0b013e3182810066

Sipponen, 2008, Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn’s disease and histological findings, Aliment Pharmacol Ther, 28, 1221, 10.1111/j.1365-2036.2008.03835.x

Jang, 2014, Clinical usefulness of double balloon enteroscopy in suspected Crohn’s disease: the KASID multi-center trial, Hepatogastroenterology, 61, 1292

Keuchel, 2007, Double balloon [push-and-pull] enteroscopy: breakthrough in the management of small intestinal strictures in Crohn’s disease?, Eur J Gastroenterol Hepatol, 19, 523, 10.1097/MEG.0b013e3280be5ae3

Seiderer, 2007, Double-balloon enteroscopy versus magnetic resonance enteroclysis in diagnosing suspected small bowel Crohn’s disease: results of a pilot study, Scand J Gastroenterol, 42, 1376, 10.1080/00365520701397867

Mensink, 2009, Double-balloon enteroscopy in Crohn’s disease patients suspected of small bowel activity: findings and clinical impact, J Gastroenterol, 44, 271, 10.1007/s00535-009-0011-4

Arulanandan, 2016, Systematic review: Safety of balloon assisted enteroscopy in Crohn’s disease, World J Gastroenterol, 22, 8999, 10.3748/wjg.v22.i40.8999

Navaneethan, 2014, Impact of balloon-assisted enteroscopy on the diagnosis and management of suspected and established small bowel Crohn’s disease, Endosc Int Open, 2, E201, 10.1055/s-0034-1377522

Möschler, 2008, [Complications in double-balloon-enteroscopy: results of the German DBE register], Z Gastroenterol, 46, 266, 10.1055/s-2007-963719

Lee, 2015, Serum albumin and prealbumin in calorically restricted, nondiseased individuals: a systematic review, Am J Med, 128, 1023.e1, 10.1016/j.amjmed.2015.03.032

Haluzík, 1999, Relationship of serum leptin levels and selected nutritional parameters in patients with protein-caloric malnutrition, Nutrition, 15, 829, 10.1016/S0899-9007(99)00177-X

Ulitsky, 2011, Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life, JPEN J Parenter Enteral Nutr, 35, 308, 10.1177/0148607110381267

Looker, 2011, Vitamin D status: United States, 2001–2006, NCHS Data Brief, 1

Zullow, 2017, Risk factors for vitamin D deficiency and impact of repletion in a tertiary care inflammatory bowel disease population, Dig Dis Sci, 62, 2072, 10.1007/s10620-017-4614-y

Castro, 2015, Lower levels of vitamin D correlate with clinical disease activity and quality of life in inflammatory bowel disease, Arq Gastroenterol, 52, 260, 10.1590/S0004-28032015000400003

Narula, 2012, Management of inflammatory bowel disease with vitamin D: beyond bone health, J Crohns Colitis, 6, 397, 10.1016/j.crohns.2011.10.015

Hwang, 2012, Micronutrient deficiencies in inflammatory bowel disease: from A to zinc, Inflamm Bowel Dis, 18, 1961, 10.1002/ibd.22906

Weisshof, 2015, Micronutrient deficiencies in inflammatory bowel disease, Curr Opin Clin Nutr Metab Care, 18, 576, 10.1097/MCO.0000000000000226

Rutgeerts, 1984, Natural history of recurrent Crohn’s disease at the ileocolonic anastomosis after curative surgery, Gut, 25, 665, 10.1136/gut.25.6.665

Rutgeerts, 1990, Predictability of the postoperative course of Crohn’s disease, Gastroenterology, 99, 956, 10.1016/0016-5085(90)90613-6

Fumery, 2017, Systematic review with meta-analysis: recurrence of Crohn’s disease after total colectomy with permanent ileostomy, Aliment Pharmacol Ther, 45, 381, 10.1111/apt.13886

Hukkinen, 2016, Fecal calprotectin in the prediction of postoperative recurrence of Crohn’s disease in children and adolescents, J Pediatr Surg, 51, 1467, 10.1016/j.jpedsurg.2016.01.017

Yamamoto, 2013, Faecal calprotectin and lactoferrin as markers for monitoring disease activity and predicting clinical recurrence in patients with Crohn’s disease after ileocolonic resection: a prospective pilot study, United European Gastroenterol J, 1, 368, 10.1177/2050640613501818

Qiu, 2015, Fecal calprotectin for evaluating postoperative recurrence of Crohn’s disease: a meta-analysis of prospective studies, Inflamm Bowel Dis, 21, 315, 10.1097/MIB.0000000000000262

Boschetti, 2015, Levels of fecal calprotectin are associated with the severity of postoperative endoscopic recurrence in asymptomatic patients with Crohn’s disease, Am J Gastroenterol, 110, 865, 10.1038/ajg.2015.30

Castiglione, 2008, Oral contrast-enhanced sonography for the diagnosis and grading of postsurgical recurrence of Crohn’s disease, Inflamm Bowel Dis, 14, 1240, 10.1002/ibd.20469

Castiglione, 2004, Bowel wall thickness at abdominal ultrasound and the one-year-risk of surgery in patients with Crohn’s disease, Am J Gastroenterol, 99, 1977, 10.1111/j.1572-0241.2004.40267.x

Maconi, 2001, Preoperative characteristics and postoperative behavior of bowel wall on risk of recurrence after conservative surgery in Crohn’s disease: a prospective study, Ann Surg, 233, 345, 10.1097/00000658-200103000-00007

Calabrese, 2009, Severity of postoperative recurrence in Crohn’s disease: correlation between endoscopic and sonographic findings, Inflamm Bowel Dis, 15, 1635, 10.1002/ibd.20948

Pallotta, 2010, Ultrasonographic detection and assessment of the severity of Crohn’s disease recurrence after ileal resection, BMC Gastroenterol, 10, 69, 10.1186/1471-230X-10-69

Cammarota, 2013, Role of bowel ultrasound as a predictor of surgical recurrence of Crohn’s disease, Scand J Gastroenterol, 48, 552, 10.3109/00365521.2013.777774

Soyer, 2010, Suspected anastomotic recurrence of Crohn disease after ileocolic resection: evaluation with CT enteroclysis, Radiology, 254, 755, 10.1148/radiol.09091165

Mao, 2013, CT enterography in evaluating postoperative recurrence of Crohn’s disease after ileocolic resection: complementary role to endoscopy, Inflamm Bowel Dis, 19, 977, 10.1097/MIB.0b013e318280758c

Biancone, 2003, Virtual colonoscopy compared with conventional colonoscopy for stricturing postoperative recurrence in Crohn’s disease, Inflamm Bowel Dis, 9, 343, 10.1097/00054725-200311000-00001

Sailer, 2008, Anastomotic recurrence of Crohn’s disease after ileocolic resection: comparison of MR enteroclysis with endoscopy, Eur Radiol, 18, 2512, 10.1007/s00330-008-1034-6

Koilakou, 2010, Endoscopy and MR enteroclysis: equivalent tools in predicting clinical recurrence in patients with Crohn’s disease after ileocolic resection, Inflamm Bowel Dis, 16, 198, 10.1002/ibd.21003

Kono, 2014, Prospective postsurgical capsule endoscopy in patients with Crohn’s disease, World J Gastrointest Endosc, 6, 88, 10.4253/wjge.v6.i3.88

Bourreille, 2006, Wireless capsule endoscopy versus ileocolonoscopy for the diagnosis of postoperative recurrence of Crohn’s disease: a prospective study, Gut, 55, 978, 10.1136/gut.2005.081851

, Capsule endoscopy, magnetic resonance enterography and small bowel ultrasound for evaluation of postoperative recurrence in Crohn’s disease: systematic review and meta-analysis

Shen, 2005, Comprehensive evaluation of inflammatory and noninflammatory sequelae of ileal pouch-anal anastomoses, Am J Gastroenterol, 100, 93, 10.1111/j.1572-0241.2005.40778.x

Gionchetti, 2003, Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial, Gastroenterology, 124, 1202, 10.1016/S0016-5085(03)00171-9

Hurst, 1998, The implications of acute pouchitis on the long-term functional results after restorative proctocolectomy, Inflamm Bowel Dis, 4, 280, 10.1097/00054725-199811000-00004

Madiba, 2001, Pouchitis following restorative proctocolectomy for ulcerative colitis: incidence and therapeutic outcome, J R Coll Surg Edinb, 46, 334

Mowschenson, 2000, Ileoanal pouch operation: long-term outcome with or without diverting ileostomy, Arch Surg, 135, 463, 10.1001/archsurg.135.4.463

Hueting, 2005, Results and complications after ileal pouch anal anastomosis: a meta-analysis of 43 observational studies comprising 9,317 patients, Dig Surg, 22, 69, 10.1159/000085356

Fazio, 1995, Ileal pouch-anal anastomoses complications and function in 1005 patients, Ann Surg, 222, 120, 10.1097/00000658-199508000-00003

McLaughlin, 2009, Guide to endoscopy of the ileo-anal pouch following restorative proctocolectomy with ileal pouch-anal anastomosis; indications, technique, and management of common findings, Inflamm Bowel Dis, 15, 1256, 10.1002/ibd.20874

Shen, 2005, Clinical approach to diseases of ileal pouch-anal anastomosis, Am J Gastroenterol, 100, 2796, 10.1111/j.1572-0241.2005.00278.x

Ghali, 2002, The role of endoscopy in the evaluation of pouches and ostomies, Gastrointest Endosc Clin N Am, 12, 605, 10.1016/S1052-5157(02)00012-0

Shen, 2010, Diagnosis and management of postoperative ileal pouch disorders, Clin Colon Rectal Surg, 23, 259, 10.1055/s-0030-1268252

Shen, 2001, Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis, Gastroenterology, 121, 261, 10.1053/gast.2001.26290

Moskowitz, 1986, An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir, Int J Colorectal Dis, 1, 167, 10.1007/BF01648445

Sandborn, 1994, Pouchitis after ileal pouch-anal anastomosis: a pouchitis disease activity index, Mayo Clin Proc, 69, 409, 10.1016/S0025-6196(12)61634-6

Shen, 2008, A proposed classification of ileal pouch disorders and associated complications after restorative proctocolectomy, Clin Gastroenterol Hepatol, 6, 145, 10.1016/j.cgh.2007.11.006

Shen, 2010, Asymmetric endoscopic inflammation of the ileal pouch: a sign of ischemic pouchitis?, Inflamm Bowel Dis, 16, 836, 10.1002/ibd.21129

Johnson, 2008, Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis, Eur J Gastroenterol Hepatol, 20, 174, 10.1097/MEG.0b013e3282f1c9a7

Farkas, 2015, Faecal matrix metalloprotease-9 is a more sensitive marker for diagnosing pouchitis than faecal calprotectin: results from a pilot study, Expert Rev Gastroenterol Hepatol, 9, 387, 10.1586/17474124.2015.965144

Matalon, 2015, Serum alpha-1 antitrypsin: a noninvasive marker of pouchitis, Inflamm Bowel Dis, 21, 589, 10.1097/MIB.0000000000000308

Colombel, 2006, Quantitative measurement and visual assessment of ileal Crohn’s disease activity by computed tomography enterography: correlation with endoscopic severity and C reactive protein, Gut, 55, 1561, 10.1136/gut.2005.084301

Solem, 2008, Small bowel imaging in Crohn’s disease: a prospective, blinded, 4-way comparison trial, Gastrointest Endosc, 68, 255, 10.1016/j.gie.2008.02.017

Voderholzer, 2005, Small bowel involvement in Crohn’s disease: a prospective comparison of wireless capsule endoscopy and computed tomography enteroclysis, Gut, 54, 369, 10.1136/gut.2004.040055

Turetschek, 2002, Findings at helical CT-enteroclysis in symptomatic patients with crohn disease: correlation with endoscopic and surgical findings, J Comput Assist Tomogr, 26, 488, 10.1097/00004728-200207000-00002

Rieder, 2017, Mechanisms, management, and treatment of fibrosis in patients with inflammatory bowel diseases, Gastroenterology, 152, 340, 10.1053/j.gastro.2016.09.047

Maconi, 2003, Small bowel stenosis in Crohn’s disease: clinical, biochemical and ultrasonographic evaluation of histological features, Aliment Pharmacol Ther, 18, 749, 10.1046/j.1365-2036.2003.01673.x

Chiorean, 2007, Correlation of CT enteroclysis with surgical pathology in Crohn’s disease, Am J Gastroenterol, 102, 2541, 10.1111/j.1572-0241.2007.01537.x

Punwani, 2009, Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging features, Radiology, 252, 712, 10.1148/radiol.2523082167

Zappa, 2011, Which magnetic resonance imaging findings accurately evaluate inflammation in small bowel Crohn’s disease? A retrospective comparison with surgical pathologic analysis, Inflamm Bowel Dis, 17, 984, 10.1002/ibd.21414

Rimola, 2015, Characterization of inflammation and fibrosis in Crohn’s disease lesions by magnetic resonance imaging, Am J Gastroenterol, 110, 432, 10.1038/ajg.2014.424

Tielbeek, 2014, Evaluation of conventional, dynamic contrast enhanced and diffusion weighted MRI for quantitative Crohn’s disease assessment with histopathology of surgical specimens, Eur Radiol, 24, 619, 10.1007/s00330-013-3015-7

Adler, 2011, Magnetization transfer helps detect intestinal fibrosis in an animal model of Crohn disease, Radiology, 259, 127, 10.1148/radiol.10091648

Dillman, 2015;42:801–10, Comparison of noncontrast MRI magnetization transfer and T2 -weighted signal intensity ratios for detection of bowel wall fibrosis in a Crohn’s disease animal model, J Magn Reson Imaging, 10.1002/jmri.24815

Dillman, 2013, US elastography-derived shear wave velocity helps distinguish acutely inflamed from fibrotic bowel in a Crohn disease animal model, Radiology, 267, 757, 10.1148/radiol.13121775

Stidham, 2011, Ultrasound elasticity imaging for detecting intestinal fibrosis and inflammation in rats and humans with Crohn’s disease, Gastroenterology, 141, 819, 10.1053/j.gastro.2011.07.027

Ripollés, 2013, Effectiveness of contrast-enhanced ultrasound for characterisation of intestinal inflammation in Crohn’s disease: a comparison with surgical histopathology analysis, J Crohns Colitis, 7, 120, 10.1016/j.crohns.2012.03.002

Girlich, 2011, Comparison between preoperative quantitative assessment of bowel wall vascularization by contrast-enhanced ultrasound and operative macroscopic findings and results of histopathological scoring in Crohn’s disease, Ultraschall Med, 32, 154, 10.1055/s-0029-1245398

Sipponen, 2010, Endoscopic evaluation of Crohn’s disease activity: comparison of the CDEIS and the SES-CD, Inflamm Bowel Dis, 16, 2131, 10.1002/ibd.21300

Bettenworth, 2017, A pooled analysis of efficacy, safety, and long-term outcome of endoscopic balloon dilation therapy for patients with stricturing Crohn’s disease, Inflamm Bowel Dis, 23, 133, 10.1097/MIB.0000000000000988

Magro, 2017;11:649–70, Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: Definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders, J Crohns Colitis, 10.1093/ecco-jcc/jjx008

Eaden, 2001, The risk of colorectal cancer in ulcerative colitis: a meta-analysis, Gut, 48, 526, 10.1136/gut.48.4.526

Jess, 2012, Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies, Clin Gastroenterol Hepatol, 10, 639, 10.1016/j.cgh.2012.01.010

Lovasz, 2013, Risk of colorectal cancer in Crohn’s disease patients with colonic involvement and stenosing disease in a population-based cohort from Hungary, J Gastrointestin Liver Dis, 22, 265

Friedman, 2001, Screening and surveillance colonoscopy in chronic Crohn’s colitis, Gastroenterology, 120, 820, 10.1053/gast.2001.22449

Yamazaki, 1991, Malignant colorectal strictures in Crohn’s disease, Am J Gastroenterol, 86, 882

Fumery, 2015, Detection of dysplasia or cancer in 3.5% of patients with inflammatory bowel disease and colonic strictures, Clin Gastroenterol Hepatol, 13, 1770, 10.1016/j.cgh.2015.04.185

Rieder, 2016, European Crohn’s and Colitis Organisation topical review on prediction, diagnosis and management of fibrostenosing Crohn’s disease, J Crohns Colitis, 10, 873, 10.1093/ecco-jcc/jjw055

Booya, 2009, CT enterography and fistulizing Crohn’s disease: clinical benefit and radiographic findings, Abdom Imaging, 34, 467, 10.1007/s00261-008-9419-1

Maconi, 2003, Contrast radiology, computed tomography and ultrasonography in detecting internal fistulas and intra-abdominal abscesses in Crohn’s disease: a prospective comparative study, Am J Gastroenterol, 98, 1545, 10.1111/j.1572-0241.2003.07521.x

Ripollés, 2013, Contrast-enhanced ultrasound in the differentiation between phlegmon and abscess in Crohn’s disease and other abdominal conditions, Eur J Radiol, 82, e525, 10.1016/j.ejrad.2013.05.043

Lee, 2009, Crohn disease of the small bowel: comparison of CT enterography, MR enterography, and small bowel follow-through as diagnostic techniques, Radiology, 251, 751, 10.1148/radiol.2513081184

Martínez, 2009, Assessment of the extension and the inflammatory activity in Crohn’s disease: comparison of ultrasound and MRI, Abdom Imaging, 34, 141, 10.1007/s00261-008-9365-y

Beets-Tan, 2001, Preoperative MR imaging of anal fistulas: Does it really help the surgeon?, Radiology, 218, 75, 10.1148/radiology.218.1.r01dc0575

Buchanan, 2002, Effect of MRI on clinical outcome of recurrent fistula-in-ano, Lancet, 360, 1661, 10.1016/S0140-6736(02)11605-9

Navarro-Luna, 2004, Ultrasound study of anal fistulas with hydrogen peroxide enhancement, Dis Colon Rectum, 47, 108, 10.1007/s10350-003-0015-8

Sudol-Szopińska, 2003, Usefulness of hydrogen peroxide enhancement in diagnosis of anal and ano-vaginal fistulas, Eur Radiol, 13, 1080, 10.1007/s00330-002-1560-6

Wedemeyer, 2004, Transcutaneous perianal sonography: a sensitive method for the detection of perianal inflammatory lesions in Crohn’s disease, World J Gastroenterol, 10, 2859, 10.3748/wjg.v10.i19.2859

West, 2004, Hydrogen peroxide-enhanced three-dimensional endoanal ultrasonography and endoanal magnetic resonance imaging in evaluating perianal fistulas: agreement and patient preference, Eur J Gastroenterol Hepatol, 16, 1319, 10.1097/00042737-200412000-00014

Schaefer, 2005, Differentiation of perianal fistulas with digital subtraction magnetic resonance fistulography, Inflamm Bowel Dis, 11, 383, 10.1097/01.MIB.0000164021.65106.cd

Fernández-Frías, 2006, Is anal endosonography useful in the study of recurrent complex fistula-in-ano?, Rev Esp Enferm Dig, 98, 573, 10.4321/S1130-01082006000800002

Maier, 2001, Evaluation of perianal sepsis: comparison of anal endosonography and magnetic resonance imaging, J Magn Reson Imaging, 14, 254, 10.1002/jmri.1181

Reginelli, 2012, Three-dimensional anal endosonography in depicting anal-canal anatomy, Radiol Med, 117, 759, 10.1007/s11547-011-0768-4

Spencer, 1998, Outcome after surgery for perianal fistula: predictive value of MR imaging, AJR Am J Roentgenol, 171, 403, 10.2214/ajr.171.2.9694464

Wright, 2015, Transperineal ultrasonography in perianal Crohn disease: a valuable imaging modality, Can J Gastroenterol Hepatol, 29, 445, 10.1155/2015/120123

Maconi, 2013, Transperineal perineal ultrasound versus magnetic resonance imaging in the assessment of perianal Crohn’s disease, Inflamm Bowel Dis, 19, 2737, 10.1097/01.MIB.0000436274.95722.e5

Sandborn, 1997, Pouchitis: risk factors, frequency, natural history, classification and public health perspective. Trends in Inflammatory Bowel Disease 1996, 51

Shen, 2004, Endoscopic balloon dilation of ileal pouch strictures, Am J Gastroenterol, 99, 2340, 10.1111/j.1572-0241.2004.40604.x

Shen, 2011, Efficacy and safety of endoscopic treatment of ileal pouch strictures, Inflamm Bowel Dis, 17, 2527, 10.1002/ibd.21644

Nadgir, 2006, MRI of complicated pouchitis, AJR Am J Roentgenol, 187, W386, 10.2214/AJR.05.1019

Thoeni, 1990, Ileoanal pouches: comparison of CT, scintigraphy, and contrast enemas for diagnosing postsurgical complications, AJR Am J Roentgenol, 154, 73, 10.2214/ajr.154.1.2104730

Sandborn, 1994, Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment, Gastroenterology, 107, 1856, 10.1016/0016-5085(94)90832-X

Broder, 2010, Ileal pouch-anal anastomosis surgery: imaging and intervention for post-operative complications, Radiographics, 30, 221, 10.1148/rg.301095084

Tonolini, 2011, Ileal pouch and related complications: spectrum of imaging findings with emphasis on MRI, Abdom Imaging, 36, 698, 10.1007/s00261-011-9693-1

Kirat, 2011, Management of leak from the tip of the “J” in ileal pouch-anal anastomosis, Dis Colon Rectum, 54, 454, 10.1007/DCR.0b013e31820481be

Pola, 2012, Strategies for the care of adults hospitalized for active ulcerative colitis, Clin Gastroenterol Hepatol, 10, 1315, 10.1016/j.cgh.2012.07.006

Imbriaco, 2001, Toxic megacolon: role of CT in evaluation and detection of complications, Clin Imaging, 25, 349, 10.1016/S0899-7071(01)00330-8

Maconi, 2004, Ultrasonographic detection of toxic megacolon in inflammatory bowel diseases, Dig Dis Sci, 49, 138, 10.1023/B:DDAS.0000011615.64250.6e

Freeman, 2002, Spontaneous free perforation of the small intestine in Crohn’s disease, Can J Gastroenterol, 16, 23, 10.1155/2002/284958

Freeman, 2014, Spontaneous free perforation of the small intestine in adults, World J Gastroenterol, 20, 9990, 10.3748/wjg.v20.i29.9990

Hyman, 2007, Anastomotic leaks after intestinal anastomosis: it’s later than you think, Ann Surg, 245, 254, 10.1097/01.sla.0000225083.27182.85

Khoury, 2009, Abdominal computed tomography for diagnosing postoperative lower gastrointestinal tract leaks, J Gastrointest Surg, 13, 1454, 10.1007/s11605-009-0925-4

Power, 2007, CT assessment of anastomotic bowel leak, Clin Radiol, 62, 37, 10.1016/j.crad.2006.08.004

Jess, 2013, Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study, Am J Gastroenterol, 108, 1869, 10.1038/ajg.2013.249

Choi, 2015, Forty-year analysis of colonoscopic surveillance program for neoplasia in ulcerative colitis: an updated overview, Am J Gastroenterol, 110, 1022, 10.1038/ajg.2015.65

Selinger, 2014, Long-term follow-up reveals low incidence of colorectal cancer, but frequent need for resection, among Australian patients with inflammatory bowel disease, Clin Gastroenterol Hepatol, 12, 644, 10.1016/j.cgh.2013.05.017

Annese, 2013, European evidence-based consensus for endoscopy in inflammatory bowel disease, J Crohns Colitis, 7, 982, 10.1016/j.crohns.2013.09.016

Thomas-Gibson, 2006, Judgement of the quality of bowel preparation at screening flexible sigmoidoscopy is associated with variability in adenoma detection rates, Endoscopy, 38, 456, 10.1055/s-2006-925259

Subramanian, 2013, Comparison of high definition with standard white light endoscopy for detection of dysplastic lesions during surveillance colonoscopy in patients with colonic inflammatory bowel disease, Inflamm Bowel Dis, 19, 350, 10.1002/ibd.23002

Watanabe, 2016, Comparison of targeted versus random biopsies for surveillance of ulcerative colitis-associated colorectal cancer, Gastroenterology, 151, 1122, 10.1053/j.gastro.2016.08.002

Kiesslich, 2003, Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis, Gastroenterology, 124, 880, 10.1053/gast.2003.50146

Hurlstone, 2005, Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation, Endoscopy, 37, 1186, 10.1055/s-2005-921032

Kiesslich, 2007, Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis, Gastroenterology, 132, 874, 10.1053/j.gastro.2007.01.048

Hlavaty, 2011, Colorectal cancer screening in patients with ulcerative and Crohn’s colitis with use of colonoscopy, chromoendoscopy and confocal endomicroscopy, Eur J Gastroenterol Hepatol, 23, 680, 10.1097/MEG.0b013e32834791b4

Carballal, 2018;67:70–8, Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD, Gut, 10.1136/gutjnl-2016-312332

Marion, 2016, Chromoendoscopy is more effective than standard colonoscopy in detecting dysplasia during long-term surveillance of patients with colitis, Clin Gastroenterol Hepatol, 14, 713, 10.1016/j.cgh.2015.11.011

Subramanian, 2011, Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease, Aliment Pharmacol Ther, 33, 304, 10.1111/j.1365-2036.2010.04525.x

Wu, 2012, The diagnostic accuracy of chromoendoscopy for dysplasia in ulcerative colitis: meta-analysis of six randomized controlled trials, Colorectal Dis, 14, 416, 10.1111/j.1463-1318.2010.02505.x

Dekker, 2007, Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis, Endoscopy, 39, 216, 10.1055/s-2007-966214

Ignjatovic, 2012, Narrow band imaging for detection of dysplasia in colitis: a randomized controlled trial, Am J Gastroenterol, 107, 885, 10.1038/ajg.2012.67

Pellisé, 2011, Narrow-band imaging as an alternative to chromoendoscopy for the detection of dysplasia in long-standing inflammatory bowel disease: a prospective, randomized, crossover study, Gastrointest Endosc, 74, 840, 10.1016/j.gie.2011.05.013

Günther, 2011, Surveillance colonoscopy in patients with inflammatory bowel disease: comparison of random biopsy versus. targeted biopsy protocols, Int J Colorectal Dis, 26, 667, 10.1007/s00384-011-1130-y

van den Broek, 2011, Pilot study of probe-based confocal laser endomicroscopy during colonoscopic surveillance of patients with longstanding ulcerative colitis, Endoscopy, 43, 116, 10.1055/s-0030-1255954

2016, Committee Opinion No. 656. Guidelines for diagnostic imaging during pregnancy and lactation, Obstet Gynecol, 127, e75, 10.1097/00006250-201602000-00055

Miller, 2002, Hyperthermic teratogenicity, thermal dose and diagnostic ultrasound during pregnancy: implications of new standards on tissue heating, Int J Hyperthermia, 18, 361, 10.1080/02656730210146890

Gowland, 2008, Temperature increase in the fetus due to radio frequency exposure during magnetic resonance scanning, Phys Med Biol, 53, L15, 10.1088/0031-9155/53/21/L01

Fleishman, 1983, Cost benefit analysis of radiological protection: a case study of remote after-loading in gynaecological radiotherapy, Br J Radiol, 56, 737, 10.1259/0007-1285-56-670-737

Bigelow, 2011, The thermal index: its strengths, weaknesses, and proposed improvements, J Ultrasound Med, 30, 714, 10.7863/jum.2011.30.5.714

Pooh, 2016, 3D/4D sonography any safety problem, J Perinat Med, 44, 125, 10.1515/jpm-2015-0225

Ray, 2016, Association between MRI exposure during pregnancy and fetal and childhood outcomes, JAMA, 316, 952, 10.1001/jama.2016.12126

Strizek, 2015, Safety of MR imaging at 1.5 T in fetuses: a retrospective case-control study of birth weights and the effects of acoustic noise, Radiology, 275, 530, 10.1148/radiol.14141382

Stern, 2014, Magnetic resonance enterography in pregnant women with Crohn’s disease: case series and literature review, BMC Gastroenterol, 14, 146, 10.1186/1471-230X-14-146

Heetun, 2014, Magnetic resonance colonography for assessment of acute severe colitis in pregnancy, Ir J Med Sci, 183, 147, 10.1007/s11845-013-0969-z

Witherspoon, 2010, Successful pregnancy after laparoscopic ileal pouch-anal anastomosis complicated by small bowel obstruction secondary to a single band adhesion, Colorectal Dis, 12, 490, 10.1111/j.1463-1318.2009.01855.x

Savoye, 2006, Gastrointestinal: fistulae in Crohn’s disease, J Gastroenterol Hepatol, 21, 621, 10.1111/j.1440-1746.2006.04346.x

Blot, 1973, Mental retardation following in utero exposure to the atomic bombs of Hiroshima and Nagasaki, Radiology, 106, 617, 10.1148/106.3.617

Patel, 2007, Imaging the pregnant patient for nonobstetric conditions: algorithms and radiation dose considerations, Radiographics, 27, 1705, 10.1148/rg.276075002

Doll, 1997, Risk of childhood cancer from fetal irradiation, Br J Radiol, 70, 130, 10.1259/bjr.70.830.9135438

Hurwitz, 2006, Radiation dose to the fetus from body MDCT during early gestation, AJR Am J Roentgenol, 186, 871, 10.2214/AJR.04.1915

van der Woude, 2015, The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease, J Crohns Colitis, 9, 107, 10.1093/ecco-jcc/jju006

Harbord, 2016, The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease, J Crohns Colitis, 10, 239, 10.1093/ecco-jcc/jjv213

Scholar Hub - Công cụ hỗ trợ trích dẫn và phân tích khoa học Việt Nam

Về chúng tôi

Scholar Hub là công cụ hỗ trợ trích dẫn và phân tích các bài báo, công bố khoa học Việt Nam. Công cụ trợ giúp người nghiên cứu, tạp chí, đơn vị nghiên cứu tra cứu, phân tích và thống kê dữ liệu nghiên cứu khoa học tại Việt Nam và quốc tế.

Thông tin, cập nhật

Đăng ký Tạp chí tham gia vào Scholar Hub

Phản hồi ý kiến về Scholar Hub

Bài viết, nội dung cập nhật

Chủ đề khoa học

Website liên kết

Phần mềm kiểm tra trùng lặp Kiểm Tra Tài Liệu

Phần mềm xuất bản tạp chí điện tử VOJS

Công cụ kiểm tra chính tả và thể thức Viver

Nền tảng trắc nghiệm và đề thi đa lĩnh vực LetQA